The Programme Strategy Committee meets at least twice a year to oversee the implementation of the programmatic strategy and award grants.

Our Programme Strategy Committee members act in a voluntary role and do not get paid for the work they do for us.

The Programme Strategy Committee members are drawn widely and include leading scientists and research managers from academia and industry from across the globe.

Each brings a unique set of strategic, scientific and managerial experience, helping to ensure that AREF makes the best possible contribution to developing research capacity for medical and health research in Africa.

Professor Tumani Corrah (Chair)

Professor Corrah, who is Gambian, is the Founder and President of AREF. He has over thirty years of progressively senior-level research and leadership experience, ten years of which were as the Unit Director of the Medical Research Council’s Unit in The Gambia, where he is now Emeritus Director.

He is medically qualified and has retained active research interests in tropical and infectious diseases, including tuberculosis, HIV and malaria.

Professor Corrah is an Honorary Fellow of the London School of Hygiene and Tropical Medicine and is a member of over twenty scientific board and committee groups worldwide. 

Professor Richard A. Adegbola

A microbiologist, Richard Adegbola is a Consultant and Research Professor at the Nigerian Institute of Medical Research and a Professor/Independent Consultant in Immunisation and Global Health at RAMBICON. He was a member of the World Health Organisation's (WHO) Meningitis Vaccine Project Advisory Group, and was Vice Chair of the European and Developing Countries Clinical Trials Partnership Board.

He is a member of the WHO Africa Regional Immunisation Technical Advisory Group and serves as a member and Chair of several international scientific advisory boards. He is also a Trustee of the Expanded Civil Society Initiative on Immunisation in Nigeria.

Professor Danny Altmann

Danny Altmann is an active research scientist, running a research programme as Professor of Immunology at Imperial College, Hammersmith Hospital. His main research interests are adaptive immunity in human disease, including severe viral and bacterial infection and autoimmune diseases.

Danny has been nominated by the Medical Research Foundation to serve on the Committee.

Alpha Barry

Formerly the Country Managing Partner of the Gambia practice of Deloitte, Alpha Barry is a Fellow of the Chartered Association of Certified Accountants and founded Alpha Kapital Advisory, a boutique financial advisory practice, in 2013.

He serves as its Chair, as well as Chair of the Standard Chartered Bank Gambia Ltd and The Gambia Ports Authority.

 

Dr Wendy Ewart

Wendy Ewart joined the Medical Research Council (MRC) in 2008 as Director of Strategy and from 2012-2014 served as Deputy Chief Executive and Chief of Strategy, where she was responsible for the development and communication of its research strategy and impact.

She also directed international policy, including global health, and led the overall approach to planning and evaluation across the MRC.

Wendy currently chairs the Independent Evaluation Panel for the Welsh Government's Ser Cyrmu funding programme.

 

Professor Rose Leke

Rose Leke is a malariologist and Emeritus Professor of Immunology and Parasitology at the University of Yaounde, Cameroon.

She has served on many committees for the World Health Organisation including: the Malaria Policy Advisory Committee, Chair of the African Regional Commission for the Certification of the Eradication of Poliomyelitis, a member of the Global Certification Commission.

 

Professor Nyovani Madise

Nyovani is the Director of Research and Development Policy, and Head of the Malawi office, of the African Institute for Development Policy. She was formerly Professor of Demography and Social Statistics at the University of Southampton (UK).

Nyovani sits on several scientific advisory committees including the UK Department of Health and Social Care, the Dutch SRHR programme of NWO-WOTRO, and UK Research and Innovation committees (Global Challenges Research Fund and Medical Research Council Applied Global Health Board).